newsfilter
← Latest News
PR Newswire·

Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy

ROCKVILLE, Md., Jan. 31, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair, and